Navigation Links
Vaccine for Asbestos-Related Cancer Looks Safe
Date:3/4/2010

In tests, novel immunotherapy appears to combat mesothelioma tumors

THURSDAY, March 4 (HealthDay News) -- An investigational vaccine for the asbestos-related cancer mesothelioma is safe, according to a new study.

Researchers in the Netherlands tested the vaccine -- which infuses a patient's own dendritic cells with antigen from the patient's tumor -- on 10 patients and found that it induced an immune T-cell response against mesothelioma tumors.

This is the first time DC-based immunotherapy has been tested in patients with mesothelioma, which typically occurs in the lungs but can arise at other body sites. The study was published online March 4 in advance of an upcoming print issue of the American Journal of Respiratory and Critical Care Medicine.

Asbestos has been banned in developed countries for decades, but the incidence of mesothelioma is expected to continue to increase until 2020. Median survival after mesothelioma diagnosis is about 12 months. The standard chemotherapy treatment improves survival by about three months.

"The possibility to harness the potency and specificity of the immune system underlies the growing interest in cancer immunotherapy," study author Dr. Joachim Aerts, a pulmonary physician at Erasmus Medical Center, said in a news release. "One such approach uses the patient's own [dendritic cells] to present tumor-associated antigens and thereby generate tumor-specific immunity."

Dendritic cells are a form of immune system cell.

"The major problem in mesothelioma is that the immunosuppressive environment caused by the tumor will negatively influence our therapy so we are now working on a method to lower this immunosuppressive environment," Aerts said. "We hope that by further development of our method it will be possible to increase survival in patients with mesothelioma and eventually vaccinate persons who have been in contact with asbestos to prevent them from getting asbestos related diseases."

More information

The U.S. National Cancer Institute has more about mesothelioma.



-- Robert Preidt



SOURCE: American Thoracic Society, news release, March 4, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Groundbreaking research to find vaccine for hepatitis C
2. Possible vaccine for mesothelioma proven safe
3. The Coalition for Vaccine Safety Calls for Congressional Hearings on Federal Agencies Failure to Provide Adequate Safety Research
4. Texas-based consortium announces groundbreaking vaccine research program
5. New Technology Could Widen Reach of Vaccines
6. Screens, Vaccine for HPV Less Beneficial in Older Women
7. New strategy produces promising advance in cancer vaccines
8. Vaccine Not Fail-Safe in Ongoing Mumps Outbreak
9. Vaccine May Prevent TB in People With HIV
10. Mimotopes Awarded Major Peptide Supply Contract by the Queensland Institute of Medical Research in the Search for an Effective Malaria Vaccine
11. UM School of Medicine scientists find new malaria vaccine is safe and promotes immune response in children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... ... ... Erlanger Agency has announced a new partnership in its ongoing community involvement ... the fight against breast cancer, fundraising for a local woman named Carmen, who is ... is a loving single mother of two boys who also serves as caregiver for ...
(Date:2/12/2016)... ... 2016 , ... Donor Network West, the organ procurement organization that heals lives ... San Ramon Regional Medical Center. Under the collaboration, the first of its kind, specific ... a more certain time frame for donor families for the recovery of organs. ...
(Date:2/12/2016)... ... February 12, 2016 , ... For Coast Dental dentist Everet Lake, ... and dental assistant Terrell Moore shortly before 7 a.m. to volunteer at Friday’s Dentistry ... donating their time and skills to help hundreds of uninsured and underinsured people receive ...
(Date:2/12/2016)... , ... February 12, 2016 , ... ... Cancer Care.” , The print component of “Revolutionizing Cancer Care” is ... New York, Washington DC/Baltimore, and Seattle, with a circulation of approximately 250,000 copies ...
(Date:2/12/2016)... ... February 12, 2016 , ... Atlantic ... for Health Plans and PBMs,” an upcoming Feb. 24 webinar that will discuss ... in big-dollar therapeutic categories, such as the $1,000-per-pill hepatitis C treatment Sovaldi and ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... 2016  Governor Andrew M. Cuomo today announced a ... throughout Western New York . This ... Polytechnic Institute, includes a major expansion of Athenex,s North ... Buffalo , as well as the creation of ... Dunkirk . The combined projects are expected ...
(Date:2/11/2016)... , Feb. 11, 2016 AAIPharma ... provider of custom manufacturing and development services for ... sterile fill-finish capabilities and capacity in its ... in demand has driven several recent investments. ... it had one filling line with small-scale lyophilization. ...
(Date:2/11/2016)... -- Proliant Biologicals is proud to announce the opening of ... The facility is located on the North Island of ... Boone , Iowa.  The equipment design ... in the U.S. facility, with critical processing systems coming ... --> Boone , Iowa.  The ...
Breaking Medicine Technology: